Helituspan

Helituspan is an over‑the‑counter herbal product that contains a dry extract of Hederae folium (ivy leaf) standardized to a 5‑7.5:1 ratio, extracted with 30 % ethanol (m/m). The preparation is supplied in oral dosage form, although specific strength and tablet or liquid form are not disclosed. It is marketed within the European Union as a respiratory expectorant derived from a traditional plant source for use in adults.

Helituspan is indicated for the symptomatic relief of coughs associated with increased mucus production. It is commonly used in mild to moderate respiratory conditions where facilitation of expectoration is desired.

- Acute cough due to common cold or upper respiratory tract infection. - Productive cough associated with acute bronchitis. - Cough accompanying mild viral respiratory infections. - Supportive therapy for chronic bronchitis with intermittent mucus over‑production. - Adjunctive use during recovery from sinusitis‑related cough. - Relief of cough during mild asthma exacerbations where mucus clearance is needed. - Use as a non‑prescription option for cough in children over six years old, following appropriate dosing.

Helituspan is generally well tolerated, but as with any herbal preparation, some users may experience mild or, rarely, more significant reactions.

Common: - Mild gastrointestinal discomfort, such as nausea, stomach upset or mild abdominal cramping, typically transient. - Transient increase in salivation that resolves shortly after dosing. - Light‑headedness or dizziness, especially upon rapid standing, usually brief. - Slight bitter after‑taste in the mouth that dissipates within minutes. - Mild headache that resolves without medication. - Temporary dry‑mouth sensation that improves with fluid intake.

Serious: - Allergic skin reactions, including rash, itching, or urticaria, requiring discontinuation. - Swelling of the face, lips, tongue, or throat suggestive of angioedema, which may need medical attention. - Severe gastrointestinal upset with persistent vomiting or diarrhea, warranting evaluation.

Helituspan should be used with awareness of certain safety considerations to minimize risk. Users should follow label instructions and consider individual health factors before taking the product.

- Do not exceed the recommended daily dose indicated on the packaging. - Avoid use in individuals with known hypersensitivity to ivy or related plants. - Consult a healthcare professional before use during pregnancy or breastfeeding. - Discontinue use and seek medical advice if signs of an allergic reaction appear. - Use caution in patients with asthma, as increased bronchial secretions may affect breathing. - Keep out of reach of children; accidental ingestion may cause adverse effects.

Helituspan may interact with certain medications or substances; awareness of these interactions helps ensure safe and effective use.

Avoid: - Concurrent use with other herbal expectorants or mucolytics, which may cause excess bronchial secretions. - Combination with monoamine oxidase inhibitors (MAOIs) or drugs affecting respiratory smooth muscle, due to limited safety data.

Use with caution: - Antitussives such as codeine or dextromethorphan, which may counteract the expectorant effect. - Bronchodilators (e.g., β2‑agonists) may have additive airway‑tone effects. - Antihistamines can dry secretions, possibly reducing expectorant action. - Patients on anticoagulants should monitor for possible changes in platelet function. - Herbal supplements such as St. John's wort may alter metabolism; consult a healthcare professional.